The price of Bitcoin remained above the $62,000 mark, influenced by growing optimism for a comprehensive U.S. cryptocurrency bill and continued institutional interest. The developments come amid a backdrop of ongoing security concerns and high volatility in the broader digital asset market.
Bitcoin is trading just below the key resistance level of $63,300, with technical analysis suggesting that while the short-term trend remains bullish, upward momentum may be weakening.
A Citi analyst has identified top stock picks in the Life Science Tools & Diagnostics sector for the latter half of 2026, citing cautious optimism for a market recovery and a more positive view on the role of artificial intelligence.
A federal judge has rejected a request by prediction market platform Kalshi for a preliminary injunction to stop New York from enforcing its state gambling laws. The ruling marks a significant point in the ongoing jurisdictional dispute between state and federal regulators over the growing industry.
Russia has reportedly implemented a ban on all diesel exports to prevent domestic shortages following a series of Ukrainian drone attacks on its oil refineries. The move is expected to add pressure to global fuel markets.
Options market data indicates a potential 4.3% price swing for Johnson & Johnson stock following its earnings report scheduled for July 15. The healthcare company's stock has exceeded the options-implied move in three of its last eight earnings announcements.
Shares of Definium Therapeutics rallied after investment firm Stifel doubled its price target for the stock to $60. The upgrade was prompted by stronger-than-expected Phase 3 clinical data for the company's lead depression drug candidate, DT120.
Expedia's stock price declined over 4% in morning trading as investors took profits following a recent 17% surge. The drop was compounded by a lack of fresh catalysts and a wider market downturn affecting the travel sector.
Shares of Navitas Semiconductor declined on Tuesday after competitor Wolfspeed filed a lawsuit alleging patent infringement across a wide range of the company's core products. The legal challenge adds to existing pressures on the stock, including a broader market downturn and concerns over potential share dilution.
